These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

511 related articles for article (PubMed ID: 8185423)

  • 1. Usefulness of soluble interleukin 2 receptor in differentiating tuberculous and carcinomatous pleural effusions.
    Chang SC; Hsu YT; Chen YC; Lin CY
    Arch Intern Med; 1994 May; 154(10):1097-101. PubMed ID: 8185423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preliminary evaluation of soluble IL-2 receptor and type III procollagen N-terminal aminopeptide in pleural fluid for differentiating tuberculous, carcinomatous and parapneumonic pleural effusions.
    Harita S; Nogami N; Kikuchi T; Kibata M
    Respirology; 2002 Dec; 7(4):311-5. PubMed ID: 12421238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pleural fluid and serum soluble interleukin-2 receptors in pleural effusions.
    Sarandakou A; Poulakis N; Rizos D; Phocas I
    Anticancer Res; 1991; 11(3):1365-8. PubMed ID: 1888173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnosis of tuberculous pleuritis by the measurement of soluble interleukin 2 receptor in pleural fluid.
    Porcel JM; Gázquez I; Vives M; Pérez B; Rubio M; Rivas MC
    Int J Tuberc Lung Dis; 2000 Oct; 4(10):975-9. PubMed ID: 11055766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical significance of soluble interleukin 2 receptor alpha in the pleural fluid].
    Ni SS; Gao ZL
    Zhonghua Jie He He Hu Xi Za Zhi; 1993 Feb; 16(2):81-2, 123. PubMed ID: 8221956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Elevated soluble interleukin-2 receptor and interleukin-2 receptor positive cells in carcinomatous pleural effusions].
    Kojiro N; Moriwaki Y; Ito M; Nishiki M; Shirasaka T; Kokubu T
    Nihon Kyobu Shikkan Gakkai Zasshi; 1990 Jan; 28(1):100-4. PubMed ID: 2355670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gamma-interferon and soluble interleukin 2 receptor in tuberculous pleural effusion.
    Kim YK; Lee SY; Kwon SS; Kim KH; Moon HS; Song JS; Park SH
    Lung; 2001; 179(3):175-84. PubMed ID: 11891607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pleural fluid soluble interleukin 2 receptor in rheumatoid arthritis and systemic lupus erythematosus.
    Pettersson T; Söderblom T; Nyberg P; Riska H; Linko L; Klockars M
    J Rheumatol; 1994 Oct; 21(10):1820-4. PubMed ID: 7837144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute phase markers for the differentiation of infectious and malignant pleural effusions.
    Kiropoulos TS; Kostikas K; Oikonomidi S; Tsilioni I; Nikoulis D; Germenis A; Gourgoulianis KI
    Respir Med; 2007 May; 101(5):910-8. PubMed ID: 17270413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic value of vascular endothelial growth factor and endostatin in malignant pleural effusions.
    Zhou WB; Bai M; Jin Y
    Int J Tuberc Lung Dis; 2009 Mar; 13(3):381-6. PubMed ID: 19275801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of pleural fluid C-reactive protein in laboratory diagnosis of pleural effusions.
    Castaño Vidriales JL; Amores Antequera C
    Eur J Med; 1992; 1(4):201-7. PubMed ID: 1341445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Triggering receptor expressed on myeloid cells-1 in pleural effusions: a marker of inflammatory disease.
    Liu CL; Hsieh WY; Wu CL; Kuo HT; Lu YT
    Respir Med; 2007 May; 101(5):903-9. PubMed ID: 17097866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neopterin, soluble interleukin-2 receptor and adenosine deaminase levels in pleural effusions.
    Chiang CS; Chiang CD; Lin JW; Huang PL; Chu JJ
    Respiration; 1994; 61(3):150-4. PubMed ID: 8047718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differentiating tuberculous from malignant pleural effusions: a scoring model.
    Porcel JM; Vives M
    Med Sci Monit; 2003 May; 9(5):CR175-80. PubMed ID: 12761453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determination of adenosine deaminase activity and its isoenzymes for diagnosis of pleural effusions.
    Gorguner M; Cerci M; Gorguner I
    Respirology; 2000 Dec; 5(4):321-4. PubMed ID: 11192541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated soluble CD26 levels in patients with tuberculous pleurisy.
    Oshikawa K; Sugiyama Y
    Int J Tuberc Lung Dis; 2001 Sep; 5(9):868-72. PubMed ID: 11573900
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of interferon-gamma, interferon-gamma-inducing cytokines, and interferon-gamma-inducible chemokines in tuberculous pleural effusions.
    Okamoto M; Kawabe T; Iwasaki Y; Hara T; Hashimoto N; Imaizumi K; Hasegawa Y; Shimokata K
    J Lab Clin Med; 2005 Feb; 145(2):88-93. PubMed ID: 15746651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A simple C-reactive protein measurement for the differentiation between tuberculous and malignant pleural effusion.
    Chierakul N; Kanitsap A; Chaiprasert A; Viriyataveekul R
    Respirology; 2004 Mar; 9(1):66-9. PubMed ID: 14982604
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Osteopontin is upregulated in malignant and inflammatory pleural effusions.
    Moschos C; Porfiridis I; Psallidas I; Kollintza A; Stathopoulos GT; Papiris SA; Roussos C; Kalomenidis I
    Respirology; 2009 Jul; 14(5):716-22. PubMed ID: 19476604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of a new inflammatory molecule (triggering receptor expressed on myeloid cells-1) in the diagnosis of pleural effusion.
    Chan MC; Chang KM; Chao WC; Lin LY; Kuo BI; Hsu JY; Wu CL
    Respirology; 2007 May; 12(3):333-8. PubMed ID: 17539835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.